The effect of organospecific peptides on morphological changes in kidneys of rats with ischemia-reperfusion kidney injury.
DOI:
https://doi.org/10.26641/1997-9665.2016.3.165-169Keywords:
Ischemia-reperfusion kidney injury, morphological changes, organospecific peptides, renoprotectionAbstract
Background. Renal ischemia/reperfusion (I/R) accounts for a significant number of acute kidney injury cases in humans. It calls forth the search of novel therapies able to prevent progression and improve prognosis by the protection of tubular cells and restoration of tubular function. Objective. To study the histopathological changes in kidneys of rats with I/R with estimation of the renoprotective potential of the organospecific peptides — peptide kidney complex (PKC), synthetic peptides AED, EDL and AEDG. Methods. The study was conducted on 42 non-linear rats. Renal I/R was modeled by the clamping of both renal pedicles during 60 min following by 24-hour reperfusion. Documentation of the pathological processes was performed by the computer morphometry of objects in histological preparations. Results. Development of the I/R kidney injury resulted in the significant pathological changes in kidney tissue: coagulative necrosis of the 54±3.2% epithelial cells of proximal tubules with the signs of hydropic vacuolization or ballooning degeneration in the rest of cells; 35±2.2% of glomeruli are swollen, some are deformed. In the medulla tubular lumen are dilated and filled with hyaline casts, vascular plethora, hemorrhages and subendothelial edema are found. Use of organospecific peptides PKC, EDL and AEDG contributes to the restraint of the histopathological changes, which is confirmed by the decrease of the prevalence and severity of tubular necrosis and dystrophy. Peptide EDL also prevents the injury of glomeruli. Conclusion. Obtained results verify the more significant protective effect of synthetic peptides EDL and AEDG, less marked mitigation of injury under the influence of PCK along with the absence of significant improvement of kidney histopathology in case of peptide AED use.
References
- Krishnamoorthy A, Ajay AK, Hoffmann D, Tae-Min K, Ramirez V, Campanholle G, Boba-dilla NA. Fibrinogen β–derived Bβ15-42 peptide protects against kidney ischemia/reperfusion injury. Blood. 2011;118(7):1934-42. DOI: 10.1182/blood-2011-02-338061.
- Urbschat A, Zacharowski K, Obermüller N, Rupprecht K, Penzkofer D, Jennewein C. The small fibrinopeptide Bβ15–42 as renoprotective agent preserving the endothelial and vascular integrity in early ischemia reperfusion injury in the mouse kidney. PLoS ONE. 2014;9(1):e84432. DOI: 10.1371/journal.pone.0084432
- Yalavarthy R, Edelstein CL. Therapeutic and predictive targets of AKI. Clin Nephrol. 2008;70(6):453-63. PMID: 19049701
- Ahmad QZ, Jahan N, Ahmad G, Tajuddin. An appraisal of nephroprotection and the scope of natural products in combating renal disor-ders. J Nephrol Ther. 2014;4:170. DOI: 10.4172/2161-0959.1000170
- Lempiainen J, Finckenberg P, Mervaala E. Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury. Pharma Res Per. 2014;2(3):e00045. DOI: 10.1002/prp2.45
- Zamorskii II, Shchudrova TS, Lin’kova NS, Nichik TE, Khavinson VKh. Peptides restore functional state of the kidneys during cisplatin-induced acute renal failure. Bull Exp Biol Med. 2015;159:736-9. DOI: 10.1007/s10517-015-3062-y
- Zamorskii II, Shchudrova TS. Main mechanisms of rhabdomyolysis caused kidney injury and their correction by organospecific peptides. Biophysics. 2014;59:834-6. DOI: 10.1134/S0006350914050315
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Morphologia
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world.
The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.
